Detected ·
Immitra Bio GmbH
CHF 2.4M—
Immitra Bio GmbH raised CHF 2.4M in a pre-seed financing round to develop in-vivo gene editing therapies by activating natural backup genes instead of replacing defective ones. The round was co-led by BackBone Ventures and OCCIDENT, with participation from another.vc, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation, Gebert Rüf Stiftung, and select private investors.
- Website
- immitrabio.com
- linkedin.com/company/immitra-bio
- Amount
- CHF 2 400 000 CHF
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-21 12:11:14 UTC
- Signal ID
- eaa65c81-b349-4bf8-8295-c1a71fdee496
As the API returns it
{
"id": "eaa65c81-b349-4bf8-8295-c1a71fdee496",
"created_at": "2026-07-21T12:11:14.562364Z",
"company_name": "Immitra Bio GmbH",
"company_website_url": "immitrabio.com",
"company_linkedin_url": "https://www.linkedin.com/company/immitra-bio",
"event_type": "funding",
"funding_amount": 2400000,
"funding_currency": "CHF",
"funding_stage": null,
"message": "*Immitra Bio GmbH raised CHF 2.4M in a pre-seed financing round to develop in-vivo gene editing therapies by activating natural backup genes instead of replacing defective ones. The round was co-led by BackBone Ventures and OCCIDENT, with participation from another.vc, Kickfund, Venture Kick, Zürcher Kantonalbank, FONGIT, ETH Foundation, Gebert Rüf Stiftung, and select private investors.*"
}